Blanket Purchase Agreement GS02F0126S-75F40120A00032

Award Date 9/15/20
Last Date to Order 9/20/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian agency, to the American Institutes for Research in the Behavioral Sciences (AIR), a non-profit research organization. The BPA has a ceiling value of $90,000,000 and a period of performance through January 7, 2026. It is not set aside for small businesses. The BPA is for "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" and allows the FDA to procure AIR's research, evaluation, and...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian agency, to LMI Consulting, LLC, a for-profit management consulting firm. The BPA has a ceiling value of $149,000,000 and an ultimate completion date of March 26, 2028. It covers a broad range of professional services, including strategic planning, new business model development, organizational change management, policy effectiveness studies, resource and risk modeling, program and project...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to American Public Training LLC, doing business as Graduate School USA, a for-profit limited liability company. The contract has a ceiling value of $1,500,000 and a period of performance from August 28, 2024 to August 27, 2029. Under this BPA, Graduate School USA will provide professional and management development training services to the FDA's Office of Human...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian agency, to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm. The BPA has a ceiling value of $149,000,000 and a period of performance through March 26, 2028. The BPA aims to procure technical and management consulting services to support the FDA's efforts to optimize and modernize its business operations, aligning them with strategic priorities and...
This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to American Public Training LLC, doing business as Graduate School USA, a for-profit limited liability company. The $3.5 million BPA, awarded under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle, is for the FDA's Center for Food Safety and Applied Nutrition (CFSAN) school-based education program. The contract provides a range of...
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Booz Allen Hamilton Inc. as a single-award contract vehicle under the Multiple Award Schedule contracting vehicle. With a potential value of $90 million and a period of performance through October 2026, the BPA aims to procure scientific services in support of EO 14042 as described in the contract description. The BPA establishes an indefinite delivery/indefinite quantity...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Booz Allen Hamilton Inc., a prominent management and technology consulting firm. The contract has a total ceiling value of $90,000,000 and a period of performance through January 7, 2026. The BPA is intended to provide the FDA with "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" across a range of professional service areas. As a single-award BPA issued under...
The Blanket Purchase Agreement (BPA) with contract ID 47QTCA19D002D|75F40125A00010 was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the small business prime contractor Team Carney, Inc. (doing business as Carney Inc.). The $99,500,000.00 BPA has a period of performance running through June 19, 2030 and is intended to provide the FDA with a suite of human capital integrated services, including instructional systems design, course development, eLearning...
The Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Technology Solutions Provider, Inc. as a single-award contract under the Multiple Award Schedule. With a potential value of $140 million, the BPA aims to procure workflow management services for the FDA's Center for Drug Evaluation and Research over a five-year period of performance ending in April 2026. The BPA will facilitate task orders related to the CDER...
This is a Blanket Purchase Agreement (BPA) contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Westat, Inc., a prominent professional services firm. The BPA has a ceiling value of $90,000,000 and a period of performance through January 7, 2026. The BPA is for "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" to support the FDA across a variety of research, data collection, analysis, and evaluation tasks. Westat has been issued multiple task...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $5 million Blanket Purchase Agreement (BPA) to the American Society For Quality, Inc. (ASQ), a non-profit organization, to provide quality management training services. The BPA is a single-award, government-wide acquisition contract vehicle that runs through September 2025.

Under the BPA, the FDA has issued three task orders to-date valued at a total of $383,083. The task orders cover a range of quality management training, including Lean Six Sigma, quality assurance, auditing, and regulatory compliance for medical devices and radiological health. The training is to be delivered on-site at FDA facilities in Silver Spring, Maryland and Milwaukee, Wisconsin, or remotely, leveraging ASQ's existing GSA schedule contract pricing and terms. These training services support the FDA's public health and regulatory responsibilities by enhancing quality management capabilities across the agency.

Generated 3/29/24, 9:14 AM